Trial Profile
Phase II Trial of STI571 [imatinib mesylate] in Metastatic Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 23 Aug 2007 Status changed from in progress to completed.
- 16 Sep 2005 New trial record.